Group B Streptococcus (GBS) Invasive Infections in Women of Childbearing Age, France, 2012-2020: GBS CC-17 Hypervirulence in Intrapartum Infections

J Infect Dis. 2022 Aug 26;226(3):541-545. doi: 10.1093/infdis/jiac076.

Abstract

Group B Streptococcus (GBS) is the leading cause of neonatal infections and an important pathogen in pregnancy. However, the features of pregnancy-associated infections are poorly reported. We analyzed 336 cases of GBS invasive infections in women aged 18-50 years, including 242 (72.0%) pregnancy-associated infections. In pregnancy, most cases were intra-amniotic infections (55.8%), occurred preterm (61.3%), and were associated with obstetrical and neonatal complications (81.7%). The GBS clone CC-17 (18.8% of the cases) was overrepresented intrapartum (35.2%; odds ratio, 5.1 [95% confidence interval, 1.6-19.3]). This work highlights the burden of GBS and of the CC-17 clone infections during pregnancy.

Keywords: Streptococcus agalactiae; CC-17 clone; capsular serotype; epidemiology; group B Streptococcus; invasive infection; pregnancy; women of childbearing age.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • Humans
  • Infant, Newborn
  • Odds Ratio
  • Pregnancy
  • Pregnancy Complications, Infectious*
  • Risk Factors
  • Streptococcal Infections*
  • Streptococcus agalactiae